A fragment-based approach leading to the discovery of a novel binding site and the selective CK2 inhibitor CAM4066. (2017)

First Author: De Fusco C

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.bmc.2017.04.037

PubMed Identifier: 28495381

Publication URI: http://europepmc.org/abstract/MED/28495381

Type: Journal Article/Review

Volume: 25

Parent Publication: Bioorganic & medicinal chemistry

Issue: 13

ISSN: 0968-0896